5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 0.75▼ | 0.76▼ | 0.77▼ | 0.78▼ | 1.05▼ |
MA10 | 0.76▼ | 0.77▼ | 0.77▼ | 0.78▼ | 1.28▼ |
MA20 | 0.77▼ | 0.78▼ | 0.79▼ | 1.06▼ | 1.55▼ |
MA50 | 0.80▼ | 0.80▼ | 0.78▼ | 1.35▼ | N/A |
MA100 | 0.79▼ | 0.83▼ | 1.03▼ | N/A | N/A |
MA200 | 0.85▼ | 1.20▼ | 1.36▼ | N/A | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | -0.001▼ | -0.003▼ | -0.003▼ | -0.013▼ | N/A |
RSI | 41.109▼ | 41.078▼ | 36.640▼ | 32.201▼ | 25.054▼ |
STOCH | 7.290▼ | 22.970 | 24.033 | 33.121 | 18.993▼ |
WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -92.085▼ | -92.297▼ |
CCI | -68.605 | -107.450▼ | -132.771▼ | -46.754 | -188.057▼ |
Wednesday, April 23, 2025 10:58 AM
MetaVia Inc. ( Nasdaq: MTVA) announced that a late-breaking abstract highlighting Phase 2a data from its DA-1241 program in presumed metabolic dysfunction-associated steatohepatitis (MASH) has been ...
|
Wednesday, April 23, 2025 05:31 AM
MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting data from its Phase 2a clinical ...
|
Tuesday, April 22, 2025 05:56 AM
(RTTNews) - MetaVia Inc. (MTVA), a clinical-stage biotechnology ... of the author and do not necessarily reflect those of Nasdaq, Inc. Founded in the late 1990s by Andrew Mariathasan in New ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
01/05/25 | 0.76 | 0.767 | 0.744 | 0.762 | 73,300 |
30/04/25 | 0.786 | 0.7898 | 0.7502 | 0.761 | 73,007 |
29/04/25 | 0.783 | 0.79 | 0.77 | 0.7825 | 82,223 |
28/04/25 | 0.83 | 0.83 | 0.78 | 0.791 | 97,900 |
25/04/25 | 0.8245 | 0.85 | 0.8007 | 0.8226 | 122,400 |
24/04/25 | 0.789 | 0.86 | 0.76 | 0.85 | 195,100 |
23/04/25 | 0.7673 | 0.8297 | 0.7446 | 0.813 | 267,029 |
22/04/25 | 0.705 | 0.789 | 0.67 | 0.75 | 1,057,700 |
21/04/25 | 0.729 | 0.77 | 0.70 | 0.733 | 304,000 |
17/04/25 | 0.70 | 0.74 | 0.647 | 0.739 | 527,850 |
|
|
||||
|
|
||||
|
|